Nutex Health Statistics
Total Valuation
Nutex Health has a market cap or net worth of $29.33 million. The enterprise value is $271.72 million.
| Market Cap | 29.33M |
| Enterprise Value | 271.72M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nutex Health has 49.72 million shares outstanding. The number of shares has increased by 14.52% in one year.
| Shares Outstanding | 49.72M |
| Shares Change (YoY) | +14.52% |
| Shares Change (QoQ) | +11.13% |
| Owned by Insiders (%) | 42.70% |
| Owned by Institutions (%) | 9.95% |
| Float | 27.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| Forward PS | 0.10 |
| PB Ratio | 0.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 4.32.
| Current Ratio | 1.68 |
| Quick Ratio | 1.60 |
| Debt / Equity | 4.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.54 |
Financial Efficiency
Return on equity (ROE) is -53.40% and return on invested capital (ROIC) is -7.72%.
| Return on Equity (ROE) | -53.40% |
| Return on Assets (ROA) | -9.50% |
| Return on Capital (ROIC) | -7.72% |
| Revenue Per Employee | $323,463 |
| Profits Per Employee | -$51,254 |
| Employee Count | 800 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 67.70 |
Taxes
| Income Tax | -3.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.92% in the last 52 weeks. The beta is 1.56, so Nutex Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -90.92% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 2.00 |
| Relative Strength Index (RSI) | 45.51 |
| Average Volume (20 Days) | 212,587 |
Short Selling Information
The latest short interest is 419,517, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 419,517 |
| Short Previous Month | 182,204 |
| Short % of Shares Out | 0.84% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 2.91 |
Income Statement
In the last 12 months, Nutex Health had revenue of $258.77 million and -$41.00 million in losses. Loss per share was -$1.06.
| Revenue | 258.77M |
| Gross Profit | 40.08M |
| Operating Income | -25.88M |
| Pretax Income | -44.77M |
| Net Income | -41.00M |
| EBITDA | -9.27M |
| EBIT | -27.15M |
| Loss Per Share | -$1.06 |
Balance Sheet
The company has $30.01 million in cash and $272.39 million in debt, giving a net cash position of -$242.39 million or -$4.88 per share.
| Cash & Cash Equivalents | 30.01M |
| Total Debt | 272.39M |
| Net Cash | -242.39M |
| Net Cash Per Share | -$4.88 |
| Equity (Book Value) | 63.02M |
| Book Value Per Share | 1.27 |
| Working Capital | 40.47M |
Cash Flow
In the last 12 months, operating cash flow was $3.26 million and capital expenditures -$5.85 million, giving a free cash flow of -$2.60 million.
| Operating Cash Flow | 3.26M |
| Capital Expenditures | -5.85M |
| Free Cash Flow | -2.60M |
| FCF Per Share | -$0.05 |
Margins
Gross margin is 15.49%, with operating and profit margins of -10.00% and -15.85%.
| Gross Margin | 15.49% |
| Operating Margin | -10.00% |
| Pretax Margin | -17.30% |
| Profit Margin | -15.85% |
| EBITDA Margin | -3.58% |
| EBIT Margin | -10.49% |
| FCF Margin | -1.00% |
Dividends & Yields
Nutex Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.52% |
| Shareholder Yield | -14.52% |
| Earnings Yield | -139.78% |
| FCF Yield | -8.86% |
Analyst Forecast
The average price target for Nutex Health is $1.00, which is 69.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.00 |
| Price Target Difference | 69.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 3, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Nutex Health has an Altman Z-Score of -0.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.82 |
| Piotroski F-Score | 5 |